Inhibitory action of roxithromycin on tumour necrosis factor-α production from mast cells in vitro

In Vivo

Volumn 13, Issue 6, 1999, Pages 503-506

  Shimane, Toshikazu ^a   Asano, Kazuhito ^a   Mizutani, Tetsuya ^a   Suzaki, Harumi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

In vitro; Mast cell; Mouse; Roxithromycin; TNF

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 8; MACROLIDE; ROXITHROMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; INFLAMMATORY DISEASE; MALE; MAST CELL; MOUSE; NONHUMAN;

EID: 0033498689     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Plewig G and Schopf E: Anti-inflammatory effects of antimicrobial agents: an in vivo study. J Invest Dermatol 65: 532-536, 1975.
2. Miyachi Y, Yoshida A, Imamura S and Niwa Y: Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 68: 449-453, 1986.
3. Miyatake H, Suzuki K, Taki F, Takagi K and Satake T: Effect of erythromycin on bronchial hyperresponsiveness in patients with bronchial asthma. Arzneimittelforschung 41: 552-556, 1991.
4. Nadel JA: Inflammation and asthma. J Allergy Clin Immunol 73: 651-653, 1984.
5. Holtzman MJ, Fabbri LM, O'Byrne PM, Gold BD, Aizawa H and Walter EH: Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis 127: 686-690, 1983.
6. Konno S, Adachi K, Asano K, Kawazoe T, Okamoto K, and Takahashi T: Influence of roxithromycin on cell-mediated immune responses. Life Sci 5: 107-112, 1992.
7. Konno S, Adachi K, Asano K, Kawazoe T, Okamoto K, and Takahashi T: Anti-allergic activity of roxithromycin: Inhibition of interleukin-5 production from mouse T lymphocytes. Life Sci 52: 25-30, 1993.
8. Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K and Adachi M: Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol 105: 308-316, 1994.
9. Galli SJ: New concepts about the mast cells. N Eng J Med 328: 257-265, 1993.
10. Gordon JR and Galli SJ: Mast cells as a source of both performed and immunological inducible TNF-α/cachetin. Nature 346: 274-276, 1990.
11. Kinet JP: The high-affinity receptor for IgE. Curr Opin Immunol 2: 499-505, 1989.
12. Bradding P:Human mast cell cytokines. Clin Exp Allergy 26: 13-19,
13. Ohno I, Ohkawa Y, Yamauchi K, Tanno Y and Takishima T: Production of tumor necrosis factor with IgE receptor triggering from sensitized lung tissue. Am J Respir Cell Mol Biol 3: 285-289, 1990.
14. Stricter RM, Kunkel SL and Bone RC: Role of tumor necrosis factor alpha in disease states and inflammation. Crit Care Med 21: S447, 1993.
15. Tosi MF, Stark JM, Smith CW, Hamedani A, Gruener DC and Infeld MD: Induction of ICAM-1 expression on human airway epitherial cells by inflammatory cytokines: effects on neutrophil-epitherial cell adhesion. Am J Respir Cell Mol Biol 7: 214-221, 1992.
16. Beyon RC, Bissonnette EY and Befus AD: Tumor necrosis factor-a dependent cytotoxity of human skin mast cells is enhanced by anti-IgE antibodies. J Immunol 147: 2253-2258, 1991.
17. Hu ZQ, Asano K, Yamazaki T and Shimamura T: Effect of lipopolysaccharide on mouse mast cell induction by a splenic cell culture system. Infect Immunol 62: 3844-3849, 1994.
18. Konno S, Adachi M, Asano K, Gonogami Y, Ikeda K, Okamoto K, Takahashi T: Suppressive effects of IPD-1151T(suplatast-tosilate) on induction of mast cells from nomal mouse splenocytes. Eur J Pharmacol 259: 15-20, 1994.
19. Gilbert HS and Ornstain L: Basophil counting with a new staining method using alcian blue. Blood 46: 279-286, 1975.
20. Koyama M, Tateno S, Shirotuka M, Yamamoto T, Hiyama M, Saito K and Okui K: Absorption, metabolism and excretion of RU28965 in human. Jpn J Chemotherapy 36: 164-183, 1989.
21. Schreiber SL and Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 13: 136-142, 1992.
22. Dumont FJ, Staruch MJ, Koprak SL, Melino MR and Sigal NH: Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol 144: 251-258, 1990.
23. Hultsch T, Martin R and Hohman RJ: The effect of immunophilin ligands rapamycin and FK-506 on prpliferation of mast cells and other hematopoietic cell lines. Mol Biol Cell 3: 981-987, 1992.
24. Schreiber SL: Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251: 283-287, 1991.
25. Hatfield SM and Roehm NW: Cyclosporine and FK506 inhibition of murine mast cell cytokine production. J Pharmacol Exp Ther 260: 680-688, 1992.
26. Wershil BK, Furuta GT, Lavigne JA, Choudhury AR, Wang ZS and Galli SJ: Dexamethasone and cyclosporin A suppress mast cell-leukocyte cytokine cascades. J Immunol 154: 1391-1398, 1995.